v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current Assets    
Cash $ 128,115 $ 79,392
Accounts receivable 44,010 33,360
Accrued interest due 625 250
Inventory on-hand    
Prepaid expenses 29,348 23,483
Total Current Assets 342,598 161,510
Investment in non-consolidated entity 79,500 79,500
Receivable on sale of inventory asset 71,731 72,107
Loans to clinics 30,300 25,000
Deposits 10,000 10,000
Fixed assets, net of depreciation 33,495 30,695
Finance lease, net 96,455 108,171
Right of use asset - operating lease, net 79,975 107,843
Total Non Current Assets 401,456 433,316
Total Assets 744,054 594,826
Current Liabilities    
Accounts payable 5,224 2,393
Payroll liabilities 153 153
Accrued interest – related party 60,681 37,915
Deferred revenue 64,000 14,000
Line of credit 835,312 600,000
Lease liability – current portion    
Operating 64,743 63,950
Finance 26,784 26,784
Total Current Liabilities 1,056,897 745,195
Long-term lease liabilities, net of current portion    
Operating 17,267 45,918
Finance 49,671 61,387
Total Non Current Liabilities 66,938 107,305
Total Liabilities 1,123,835 852,500
Stockholders' Equity (Deficit)    
Shares to be issued 152,607 152,607
Additional paid-in capital 15,467,045 15,467,045
Accumulated deficit (16,095,589) (15,973,482)
Total Stockholders' Equity (Deficit) (379,781) (257,674)
Total Liabilities and Stockholders’ Equity (Deficit) 744,054 594,826
Special 2022 Series A Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred Stock, Value, Issued 1 1
Series A Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred Stock, Value, Issued 0 0
Series C Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred Stock, Value, Issued 1,750 1,750
Common Class A [Member]    
Stockholders' Equity (Deficit)    
Common Stock, Value, Issued 94,405 94,405
Common Class B [Member]    
Stockholders' Equity (Deficit)    
Common Stock, Value, Issued 0 0
Biologics [Member]    
Inventory on-hand    
Inventory $ 140,500 $ 25,025